Sakar Healthcare Ltd
NSE:SAKAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sakar Healthcare Ltd
Free Cash Flow
Sakar Healthcare Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sakar Healthcare Ltd
NSE:SAKAR
|
Free Cash Flow
₹17.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-7%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Free Cash Flow
₹18.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Free Cash Flow
₹27B
|
CAGR 3-Years
10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
Free Cash Flow
₹540m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Free Cash Flow
₹29.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Free Cash Flow
₹13.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Sakar Healthcare Ltd
Glance View
Sakar Healthcare Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2016-10-14. The firm is engaged in the manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectable (SVP) in ampoules, vials & lyophilized injections, oral solid dosages, and research & development of the above products. The Company’s products include Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin Oral Solid and Lyophilised Injections (In Vials). The firm operates as a contract manufacturer for multinational pharmaceutical companies. The firm serves various countries such as Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering approximately 38 countries. The Company’s subsidiaries include Sakar Oncology Private Limited.
See Also
What is Sakar Healthcare Ltd's Free Cash Flow?
Free Cash Flow
17.5m
INR
Based on the financial report for Mar 31, 2025, Sakar Healthcare Ltd's Free Cash Flow amounts to 17.5m INR.
What is Sakar Healthcare Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-7%
